A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This essential cancer inhibitor protein is frequently inactivated in many kinds of malignancies, https://bookmarkuse.com/story21751917/nanobodies-revive-tumor-suppressor-p53-the-new-hope-for-tumor-therapy